Abstract:
A NEUTRAL DENSITY SOLUTION COMPRISING AN ADMIXTURE OF NIGROSIN DYE AND A CARBON BLACK DISPERSION IN DILUTE AQUEOUS SOLUTION WHICH EXHIBITS ABSORBANCE LINEARITY IN THE VISIBLE AND ULTRAVIOLET RANGE.
Abstract:
The invention is concerned with an improved probe-type of photometer, the probe of which may be inserted directly into a liquid or gas, to measure the light transmission through the fluid; and which may be used, for example, for spectrophotometric, turbidity, colorimetric, densitometer, or other measurements.
Abstract:
A microcapillary method for the diagnosis of sickle-cell disease in which a sample of unclotted blood is mixed with a reagent comprising phosphate buffer containing a non-ionic surfactant having high water solubility, a hemolyzing agent and a reducing agent, and the reaction results observed macroscopically for turbidity and then a microcapillary sample thereof observed macroscopically for color characteristics.
Abstract:
A DIAGNOSTIC TEST AND REAGENT FOR THE RAPID IDENTIFICATION OF SICKLE-CELL ANEMIA AND SICKLE-CELL TRAIT COMPRISING REACTION OF UNCLOTTED BLOOD WITH AN ADMIXTURE OF (NH4)2SO4/K2HPO4 BUFFER, PH 7-7.5, SAPONIN AND SODIUM DITHIONITE AND OBSERVATION OF THE TURBIDOMETRICCOLORMETRIC CHARACTERISTICS.
Abstract:
A SYNTHETIC CONTROL STANDARD FOR THE DETERMINATION OF CERBROSPINAL FLUID CONSTITUENTS IS PROVIDED BY DILUTING NORMAL BLOOD SERUM WITH AN AQUEOUS SOLUTION OF GLUCOSE AND SALINE TO A TOTAL PROTEIN CONCENTRATION OF 30 TO 145 MG. PER 100 ML.
Abstract:
A CONTROL STANDARD FOR THE ANALYTICAL DETERMINATION OF MULTIPLE BLOOD SERUM COMPOUNDS CONSISTING OF A MIXTURE OF AT LEAST THREE OF SAID BLOOD SERUM COMPONENTS HAVING THEIR RESPECTIVE CONCENTRATIONS INDISCRIMINATELY PREDETERMINED BY RANDOM SELECTION FROM THE RANGE OF LOWEST TO HIGHEST LEVELS OF EACH SAID COMPONENT ESTABLISHED BY INSTRUMENTATION PARAMETERS AND CLINICAL SIGNIFICANCE.
Abstract:
1377346 Diagnostic agent for detecting sicklecell disease BAXTER LABORATORIES Inc 26 March 1973 [24 March 1972] 14443/73 Heading G1B A reagent kit for use in testing blood for sicklecell disease and for distinguishing between sicklecell anemia and sickle-cell trait comprises (a) an aqueous buffer solution having a pH of from 7 to 7À5 and containing, per 100 ml of solution, from 21 to 35 grams of (NH 4 ) 2 SO 4 and from 0À5 to 2À0 grams of K 2 HPO 4 , (b) a hemolyzing agent, for example saponin, and (c) a reducing agent, for example sodium dithionite. The hemolyzing agent and the reducing agent may be in powdered form. Reagent solution prepared by mixing the contents of such kit may contain, per 100 ml of solution, from 0À01 to 2 grams of hemolyzing agent and from 0À01 to 2 grams of reducing agent. A sample of unclotted blood is mixed with a predetermined amount of reagent solution, the mixture being observed visually both before and after centrifuging. A translucent solution before centrifuging indicates normal (AA) hemoglobin whereas a turbid solution indicates either sickle-cell trait (AS) hemoglobin or sickle-cell anemia (SS) hemoglobin; a small amount of white precipitate after centrifuging indicates normal hemoglobin whereas a pink solution with red precipitate indicates sickle-cell hemoglobin and a yellow solution with red precipitate indicates sickle-cell anemia hemoglobin. The buffer solution additionally may contain a redox dye, for example methylene blue or basic fuchsin, for indicating decomposition of sodium dithionite reducing agent.